Ball & Co Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.02M Sell
14,270
-83
-0.6% -$33.1K 4.09% 9
2026
Q2
$5.2M Buy
14,353
+99
+0.7% +$33.9K 3.69% 9
2026
Q1
$5.02M Buy
14,254
+94
+0.7% +$33.5K 4.2% 8
2025
Q4
$4.63M Buy
14,160
+58
+0.4% +$18.4K 2.98% 11
2025
Q3
$3.98M Buy
14,102
+81
+0.6% +$23.5K 2.65% 10
2025
Q2
$3.91M Buy
14,021
+104
+0.7% +$29.5K 4.17% 7
2025
Q1
$4.34M Sell
13,917
-328
-2% -$96.9K 4.65% 8
2024
Q4
$3.71M Hold
14,245
– – 2.95% 7

Other funds holding AMGN

Ball & Co Wealth Management's AMGN Position: Q3 2026 in Review

Ball & Co Wealth Management reduced its Amgen (AMGN) stake by 0.58% in Q3 2026, selling an estimated $33.1K and leaving 14,270 shares worth $6.02M. The position accounts for 4.09% of the portfolio, ranked #9.

Ball & Co Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Ball & Co Wealth Management held 14,270 shares of Amgen worth $6.02M as of Q3 2026.
  • Ball & Co Wealth Management sold 83 Amgen shares in Q3 2026, an estimated $33.1K.
  • Amgen made up 4.09% of Ball & Co Wealth Management's portfolio in Q3 2026, its #9 holding.
  • Ball & Co Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Ball & Co Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.